WPI |

Mike Havrilla

BioMed News Bytes: Arena, Momenta, Vivus
on Sep 20, 2009 • ARNA, MNTA, MYL
FDA Calendar Updates: Johnson & Johnson, Cadence, Watson, Targacept
on Jul 16, 2009 • CADX, JNJ, TRGT
FDA Calendar Updates: Still Waiting on BioDelivery Sciences
on Jul 15, 2009 • BDSI, MAXY, WPI
FDA Calendar Updates: Trinity Biotech Awaiting Two Responses
on Jun 11, 2009 • NGSX, PRX, RBGPF.PK
FDA, Clinical Trial Updates: Watson Pharma, United Therapeutics, Auxilium, Dendreon
on Apr 29, 2009 • AUXL, DNDN, NVS
FDA, Clinical Trial Calendar Updates: Genzyme, Isis, Osiris, Roche, Watson
on Apr 23, 2009 • GENZ, ISIS, OSIR
Impax Labs: Strong Balance Sheet, Focused R&D
on Apr 21, 2009 • GENZ, IPXL, MYL
Momenta Pharma Pursuing a Three-Part Strategy
on Mar 06, 2009 • MNTA, NVS, TEVA
Biotech Going Generic Like Big Pharma?
on Mar 02, 2009 • AMGN, BIIB, CELG
Updated Clinical Trial and FDA Calendars
on Jan 29, 2009 • ABIO, SVNT, THRX
New Index of Health Product Innovators
on Jan 05, 2009 • AMGN, CEPH, CVTX
Stocks Offering 'Healthy' Returns
on Nov 25, 2008 • ABT, ALO, BMY
Bullish Outlook for Generic Drugs Post-Election
on Nov 03, 2008 • BRL, SLV, TAROF.PK

Articles by Ticker

AA, AAI, AAPL, AAWW, ABBC, ABFS, ABII, ABIO, ABMD, ABT, ABTL, ABV, ABX, ACAD, ACCP.OB, ACEL, ACHN, ACL, ACLI, ACOR, ACTC, ACTC.PK, ACUR, ACUS, ADAM, ADLR, ADLS, ADLS.OB, AET, AEZS, AFFX, AFFY, AFL, AGEN, AGN, AHBIF.PK, AIQ, AIRM, AIS, AKRX, ALEX, ALGT, ALK, ALKS, ALNPY.PK, ALNY, ALO, ALPMF.PK, ALTH, ALV,

Latest Comments on Mike Havrilla's Articles

drgmoney on Access Pharma Looking for Smooth U.S. MuGard Launch in 2010: Do you know if the post marketing Data on Mugard in Europe will be... more »
jay brebner on EXACT Sciences: Buy and Hold for Long-Term Upside: Thanks Charlie - I didn't know the stats off the top of my head... more »
Super Stock Timer on BioMed News Bytes: Cytori, Questcor: 11-7-09 - BUY DNDN ON THE FIRST CLOSE ABOVE 29.00 - WALTER - SUPER... more »
Charlie L on EXACT Sciences: Buy and Hold for Long-Term Upside: Agree that $300 every 3 years is a bargain compared to a $2,000... more »
jay brebner on EXACT Sciences: Buy and Hold for Long-Term Upside: $300 per test is an absolute bargain to detect CRC early. the... more »
BioGuy on A 130 / 30 Global Pharma Strategy : Good ideas, the generic pharmaceutical market will do well. My... more »
Dr. Bone on A 130 / 30 Global Pharma Strategy : This index sounds very interesting. Is there a way you can... more »
TX Gal 4Evr on Railroad Stocks Steam Ahead on Buffett’s Buy of BNI: Have you not heard of 'change' or 'growth' or 'variety'?? It's... more »
dual cit on Railroad Stocks Steam Ahead on Buffett’s Buy of BNI: Not what I want to hear from you. I have grown accustomed to you... more »
hoopdreamerz@yahoo.com on EXACT Sciences: Patience Required for Long-Term Upside: That's funny they compared their data with OncoMethylone (i had... more »
researchbio48 on Bio-Pharma, Diagnostics Buyout Binge Begins: Hi Mike - not sure how often you upday this link but I was hoping... more »
Mike Havrilla on Unilife: Medical Device Innovator Creating Jobs in Pennsylvania: NEH, The major investment and agreement with Sanofi (SNY) may give... more »
NEH on Unilife: Medical Device Innovator Creating Jobs in Pennsylvania: I love it Mike - it's exactly the kind of under-the-radar... more »
tappy on BioSante Pharma's LibiGel: Big Upside Potential: I have read your comments on Libi-Gel and they are well research... more »
tappy on BioSante Pharma's LibiGel: Big Upside Potential: I have read your comments on Libi-Gel and they are well research... more »

Latest Comments on Mike Havrilla's Articles

Mike Havrilla » Articles » WPI |

More on WPI by Mike Havrilla

Articles by Ticker

Latest Comments on Mike Havrilla's Articles

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers